Neuropace Inc balance sheet

At the end of fiscal 2025, Neuropace Inc had total assets of $106m, total liabilities of $86.5m and shareholders' equity of $19.0m. It held $21.7m in cash against $58.9m of debt: net debt of $37.2m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Neuropace Inc: balance sheet, annual
Fiscal year	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Cash and equivalents	26	19	7	18	13	22	13
Receivables	8	7	7	12	13	13	15
Inventory	7	8	10	11	13	15	18
Total current assets	55	133	98	93	81	94	86
Total assets	56	134	114	108	95	106	97
Accounts payable	1	1	2	2	3	2	4
Deferred revenue (current)	—	—	0	1	1	0	0
Total current liabilities	10	9	11	16	15	18	17
Short-term debt	2	0	—	—	—	—	—
Long-term debt	51	50	53	57	60	59	59
Total debt	53	50	53	57	60	59	59
Total liabilities	62	60	79	87	87	87	85
Shareholders' equity	−148	74	35	21	8	19	12
Non-controlling interests and other (assets − liabilities − equity)	141	—	—	—	—	—	—
Net debt (negative = net cash)	26	31	46	39	46	37	46
Shares outstanding	—	—	25m	28m	30m	34m	34m

US$ millions unless shown otherwise. Fiscal quarters.

Neuropace Inc: balance sheet, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Receivables	12	13	15	14	15	13	15	15
Inventory	12	13	14	16	18	15	17	18
Total current assets	83	81	97	94	95	94	87	86
Total assets	96	95	110	106	107	106	99	97
Accounts payable	2	3	4	5	5	2	5	4
Deferred revenue (current)	1	1	1	1	1	0	0	0
Total current liabilities	15	15	15	17	20	18	16	17
Long-term debt	59	60	60	59	59	59	59	59
Total debt	59	60	60	59	59	59	59	59
Total liabilities	86	87	86	87	89	87	84	85
Shareholders' equity	10	8	24	19	19	19	14	12
Shares outstanding	30m	30m	33m	33m	33m	34m	34m	34m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: CBLL vs NPCE DCTH vs NPCE IRMD vs NPCE

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Neuropace Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Neuropace Inc.